Lapix Therapeutics - Crunchbase Company Profile & Funding

Q: How much funding has Lapix Therapeutics raised to date?

Lapix Therapeutics has raised obfuscated.

Overview

Lapix Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Lapix Therapeutics

CB Rank

76498

Lapix Therapeutics operates as an immune system modulation company.

Founded

obfuscation

Private

Venture - Series Unknown

Boston, Massachusetts, United States

1-10

lapix.com

Health Care

Medical

Therapeutics

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Anas Fathallah: Founder
Tony Gibney: Independent Director
Past Role: IVERIC bio, Chief Business & Strategy Officer

Details

Legal Name

Lapix Therapeutics Inc.

Operating Status

Active

Company Type

For Profit

Founders

Anas Fathallah

About the Company

Lapix Therapeutics operates as an immune system modulation company. It helps by targeting therapies that delay the onset of disease, sustain response, or make partner drugs safer.

Contact Email

info@lapixtherapeutics.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

LPX-TI641

An orally bioavailable small molecule designed as a T cell immunoglobulin and mucin domain-containing protein (Tim) 3/4 receptor agonist for treating autoimmune diseases like Multiple Sclerosis.

LPX-TIGI

A preclinical asset aimed at treating Inflammatory Bowel Disease and food allergies by modulating immune responses, specifically for conditions like Crohn’s Disease and Ulcerative Colitis.

Research & Development

Lapix Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Lapix Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lapix Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lapix Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lapix Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lapix Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Lapix Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lapix Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lapix Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lapix Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Lapix Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown